ALEXA MAMONE: Open Payments
NPI 1376226845 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,909 in 86 payments from 12 companies in 2025. Trend: 2023 $131 · 2024 $853 · 2025 $1,909
Food & beverage: $1,909
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $897 |
| Lilly USA, LLC | 17 | $317 |
| Braeburn Inc. | 9 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $138 |
| Exact Sciences Corporation | 4 | $84 |
| Orexo US, Inc. | 4 | $77 |
| GlaxoSmithKline, LLC. | 3 | $74 |
| Alkermes, Inc. | 2 | $44 |
| Indivior Inc. | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $25 |
Products named: QULIPTA, VRAYLAR, MOUNJARO, BRIXADI, CAPLYTA, MAVYRET, Cologuard Collection Kit, TRELEGY ELLIPTA.
Industry payments across PA — which companies pay providers there.
